Pharvaris N.V.·4

Jul 1, 7:06 PM ET

Schikan Johannes Gerardus Christiaan Petrus 4

4 · Pharvaris N.V. · Filed Jul 1, 2026

Research Summary

AI-generated summary of this filing

Updated

Pharvaris (PHVS) Director Schikan Sells 37,600 Shares

What Happened

  • Schikan Johannes Gerardus Christiaan Petrus, a director of Pharvaris N.V. (PHVS), sold a total of 37,600 shares in two open-market transactions: 6,888 shares on 2026-06-29 at an average price of $35.05 for $241,447, and 30,712 shares on 2026-06-30 at an average price of $35.49 for $1,090,049. Total proceeds were approximately $1,331,496. These were sales (not purchases), which are often routine dispositions by insiders.

Key Details

  • Transaction dates and prices:
    • 2026-06-29: 6,888 shares at $35.05 — $241,447 (per-footnote: weighted avg price; trades ranged $35.00–$35.10)
    • 2026-06-30: 30,712 shares at $35.49 — $1,090,049 (per-footnote: weighted avg price; trades ranged $35.00–$35.90)
  • Total shares sold: 37,600; total proceeds ≈ $1,331,496.
  • Footnotes: Sales executed pursuant to a Rule 10b5-1 trading plan (scheduled sales). Weighted-average prices reported; filer offers to disclose per‑trade breakouts on request.
  • Shares owned after the transactions: Not specified in the provided filing summary.
  • Filing status: Form 4 filed 2026-07-01 for transactions on 2026-06-29 and 2026-06-30 — appears to be timely.

Context

  • A Rule 10b5-1 plan lets insiders pre-schedule trades and is commonly used to avoid timing concerns; scheduled sales under such plans do not necessarily indicate a change in view about the company. Sales are informative about liquidity but purchases typically carry stronger signals about insider confidence.

Insider Transaction Report

Form 4
Period: 2026-06-29
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-06-29$35.05/sh6,888$241,447345,879 total
  • Sale

    Common Stock

    [F1][F3]
    2026-06-30$35.49/sh30,712$1,090,049315,167 total
Footnotes (3)
  • [F1]This is a scheduled sale from 10b5-1 trading plan.
  • [F2]The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The sales prices for the transactions ranged from $35.00 to $35.10 The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F3]The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The sales prices for the transactions ranged from $35.00 to $35.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Signature
/s/ Marnus Nel, Attorney-in-Fact for Johannes Schikan|2026-07-01

Documents

1 file
  • 4
    ownership.xmlPrimary

    4